Literature DB >> 3476980

Rhode Island physicians' recognition and reporting of adverse drug reactions.

H D Scott, S E Rosenbaum, W J Waters, A M Colt, L G Andrews, J P Juergens, G A Faich.   

Abstract

Mesh：

Year:  1987        PMID： 3476980

Source DB:  PubMed          Journal:  R I Med J        ISSN： 0363-7913


× No keyword cloud information.
  18 in total

Review 1.  Intraspinal steroids: history, efficacy, accidentality, and controversy with review of United States Food and Drug Administration reports.

Authors:  D A Nelson; W M Landau
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-04       Impact factor: 10.154

2.  Adverse drug event monitoring at the Food and Drug Administration.

Authors:  Syed Rizwanuddin Ahmad
Journal:  J Gen Intern Med       Date:  2003-01       Impact factor: 5.128

Review 3.  Advances in targeted therapy: safety of biological agents.

Authors:  E C Keystone
Journal:  Ann Rheum Dis       Date:  2003-11       Impact factor: 19.103

Review 4.  The periodic safety update report as a pharmacovigilance tool.

Authors:  Michael J Klepper
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

Review 5.  The art and science of risk management: a US research-based industry perspective.

Authors:  Janice K Bush; Wanju S Dai; Gretchen S Dieck; Linda S Hostelley; Thomas Hassall
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 6.  Should we lower cholesterol as much as possible?

Authors:  Uffe Ravnskov; Paul J Rosch; Morley C Sutter; Mark C Houston
Journal:  BMJ       Date:  2006-06-03

7.  Ongoing challenges in pharmacovigilance.

Authors:  Gerald J Dal Pan
Journal:  Drug Saf       Date:  2014-01       Impact factor: 5.606

8.  [Not Available].

Authors: 
Journal:  Paediatr Child Health       Date:  2005-04       Impact factor: 2.253

9.  Children and natural health products: What a clinician should know.

Authors: 
Journal:  Paediatr Child Health       Date:  2005-04       Impact factor: 2.253

10.  Influence of attitudes on pharmacists' intention to report serious adverse drug events to the Food and Drug Administration.

Authors:  Paul Gavaza; Carolyn M Brown; Kenneth A Lawson; Karen L Rascati; James P Wilson; Mary Steinhardt
Journal:  Br J Clin Pharmacol       Date:  2011-07       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.